GLP-1s associated with reduced risk for depression, anxiety in patients with diabetes

Patients with diabetes who were prescribed GLP-1 receptor agonists were less likely to be diagnosed with depression and anxiety compared to those not on these medications. The GLP-1 receptor agonists included semaglutide, tirzepatide, dulaglutide, exenatide, and liraglutide. Patients without diabetes prescribed semaglutide also had a lower risk for anxiety and depression. Although the findings suggest…

Read More

Probiotics Could Delay Infection, Reduce Symptoms In Unvaccinated People Exposed To COVID-19 Patients

Researchers have found that probiotics, particularly lactobacillus, could delay COVID-19 infection and reduce symptoms in unvaccinated people. The study involved 182 participants who had been in contact with COVID-19 patients, with half taking a probiotic of lactobacillus and the other half receiving a placebo. Researchers found that those taking the probiotic were 60% less likely…

Read More

Coming to Terms With Your Diagnosis

Nina Beaty, a former smoker, was diagnosed with small-cell lung cancer after an unexpected finding in a low-dose CT scan in 2014. Despite the grim prognosis for metastatic small-cell lung cancer, she enrolled in a clinical trial, and after receiving immunotherapy treatment, she is now in remission. Emotions related to the diagnosis are difficult, but…

Read More

How Your Sleep Affects Your Heart

Maintaining good sleep is just as essential for heart health as diet and exercise. Lack of sleep can increase the risk of obesity, heart disease, and type 2 diabetes. Sleep deprivation can also lead to weight gain, diabetes, and heart disease, as well as reduce life expectancy. Sleep apnea and chronic insomnia are linked to…

Read More
error: Content is protected !!